AlloVir Inc

NASDAQ:ALVR   9:32:31 AM EDT
7.71
-0.12 (-1.53%)
Earnings Announcements

AlloVir Reports Second Quarter 2022 Financial Results

Published: 08/04/2022 11:37 GMT
AlloVir Inc (ALVR) - Allovir Reports Second Quarter 2022 Financial Results.
Allovir Inc- for Fiscal Year 2022, Allovir Continues to Expect Operating Expenses to Be in Range of $130 Million to $145 Million.
Allovir Inc- As of June 30, 2022, Allovir Had Cash, Cash Equivalents and Marketable Securities of $172.7 Million.
Allovir Inc - Qtrly Net Loss per Share Basic and Diluted $0.69.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.55

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.55

More details on our Analysts Page.